Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-000483-29Phase 4Completed
Phase 4 trial of terbutaline and salbutamol (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Urine concentration of salbutamol and terbutaline. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-000483-29.